Skip to main content
Erschienen in: Annals of Hematology 10/2007

01.10.2007 | Original Article

The oxidative status of blood cells in a murine model of graft-versus-host disease

verfasst von: Johnny Amer, Lola Weiss, Shoshana Reich, Michael Y. Shapira, Shimon Slavin, Eitan Fibach

Erschienen in: Annals of Hematology | Ausgabe 10/2007

Einloggen, um Zugang zu erhalten

Abstract

We studied the oxidative status of red and white blood cells during the development of graft vs host disease (GVHD) as well as the effects of treatment with antioxidants, both in vitro and in vivo. (BALB/c X C57BL/6) F1 mice were conditioned by total body radiation and, 1 day later, transplanted with semi-allogeneic C57BL/6 spleen cells. GVHD was followed by its clinical manifestations. Oxidative stress in red blood cells (RBC), neutrophils, and lymphocytes was assessed by measuring generation of reactive oxygen species and the content of reduced glutathione by flow cytometry after gating of the specific populations. Oxidative stress was noticed 3 weeks after transplantation. It was higher in mice receiving allogeneic spleen cells as compared with mice transplanted with syngeneic cells, suggesting that it was associated with GVHD. The results also demonstrated that treatment with the antioxidants N-acetylcysteine and a derivative of vitamin E (tocopherol succinate, propofol), both in vitro and in vivo, reduced the oxidative stress. The results indicate that various blood cells, including RBC, neutrophils, and lymphocytes, are under oxidative stress and that treatment with antioxidants reduced the stress and, thus, may be useful in ameliorating the severe consequences of GVHD.
Literatur
1.
Zurück zum Zitat Klingebiel T, Schlegel PG (1998) GVHD: overview on pathophysiology, incidence, clinical and biological features. Bone Marrow Transplant 21(Suppl 2):S45–S49PubMed Klingebiel T, Schlegel PG (1998) GVHD: overview on pathophysiology, incidence, clinical and biological features. Bone Marrow Transplant 21(Suppl 2):S45–S49PubMed
2.
Zurück zum Zitat Boumedine RS, Roy DC (2005) Elimination of alloreactive T cells using photodynamic therapy. Cytotherapy 7:134–143PubMedCrossRef Boumedine RS, Roy DC (2005) Elimination of alloreactive T cells using photodynamic therapy. Cytotherapy 7:134–143PubMedCrossRef
4.
Zurück zum Zitat Krenger W, Hill GR, Ferrara JL (1997) Cytokine cascades in acute graft-versus-host disease. Transplantation 64:553–558PubMedCrossRef Krenger W, Hill GR, Ferrara JL (1997) Cytokine cascades in acute graft-versus-host disease. Transplantation 64:553–558PubMedCrossRef
5.
Zurück zum Zitat de Zwart LL, Meerman JH, Commandeur JN, Vermeulen NP (1999) Biomarkers of free radical damage applications in experimental animals and in humans. Free Radic Biol Med 26:202–226PubMedCrossRef de Zwart LL, Meerman JH, Commandeur JN, Vermeulen NP (1999) Biomarkers of free radical damage applications in experimental animals and in humans. Free Radic Biol Med 26:202–226PubMedCrossRef
6.
Zurück zum Zitat Chan AC, Chow CK, Chiu D (1999) Interaction of antioxidants and their implication in genetic anemia. Proc Soc Exp Biol Med 222:274–282PubMedCrossRef Chan AC, Chow CK, Chiu D (1999) Interaction of antioxidants and their implication in genetic anemia. Proc Soc Exp Biol Med 222:274–282PubMedCrossRef
7.
Zurück zum Zitat Sgambato A, Ardito R, Faraglia B, Boninsegna A, Wolf FI, Cittadini A (2001) Resveratrol, a natural phenolic compound, inhibits cell proliferation and prevents oxidative DNA damage. Mutat Res 496:171–180PubMed Sgambato A, Ardito R, Faraglia B, Boninsegna A, Wolf FI, Cittadini A (2001) Resveratrol, a natural phenolic compound, inhibits cell proliferation and prevents oxidative DNA damage. Mutat Res 496:171–180PubMed
8.
Zurück zum Zitat Sen G, Mukhopadhyay R, Ghosal J, Biswas T (2001) Oxidative damage of erythrocytes: a possible mechanism for premature hemolysis in experimental visceral leishmaniasis in hamsters. Ann Hematol 80:32–37PubMedCrossRef Sen G, Mukhopadhyay R, Ghosal J, Biswas T (2001) Oxidative damage of erythrocytes: a possible mechanism for premature hemolysis in experimental visceral leishmaniasis in hamsters. Ann Hematol 80:32–37PubMedCrossRef
9.
Zurück zum Zitat Ueda S, Masutani H, Nakamura H, Tanaka T, Ueno M, Yodoi J (2002) Redox control of cell death. Antioxid Redox Signal 4:405–414PubMedCrossRef Ueda S, Masutani H, Nakamura H, Tanaka T, Ueno M, Yodoi J (2002) Redox control of cell death. Antioxid Redox Signal 4:405–414PubMedCrossRef
10.
Zurück zum Zitat Kohen R, Nyska A (2002) Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol Pathol 30:620–650PubMedCrossRef Kohen R, Nyska A (2002) Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol Pathol 30:620–650PubMedCrossRef
11.
Zurück zum Zitat Hershko C, Link G, Cabantchik I (1998) Pathophysiology of iron overload. Ann N Y Acad Sci 850:191–201PubMedCrossRef Hershko C, Link G, Cabantchik I (1998) Pathophysiology of iron overload. Ann N Y Acad Sci 850:191–201PubMedCrossRef
12.
Zurück zum Zitat Grune T, Sommerburg O, Siems WG (2000) Oxidative stress in anemia. Clin Nephrol 53:S18–S22PubMed Grune T, Sommerburg O, Siems WG (2000) Oxidative stress in anemia. Clin Nephrol 53:S18–S22PubMed
13.
Zurück zum Zitat Chakraborty D, Bhattacharyya M (2001) Antioxidant defense status of red blood cells of patients with beta-thalassemia and Ebeta-thalassemia. Clin Chim Acta 305:123–129PubMedCrossRef Chakraborty D, Bhattacharyya M (2001) Antioxidant defense status of red blood cells of patients with beta-thalassemia and Ebeta-thalassemia. Clin Chim Acta 305:123–129PubMedCrossRef
14.
Zurück zum Zitat Hedley DW, Chow S (1994) Evaluation of methods for measuring cellular glutathione content using flow cytometry. Cytometry 15:349–358PubMedCrossRef Hedley DW, Chow S (1994) Evaluation of methods for measuring cellular glutathione content using flow cytometry. Cytometry 15:349–358PubMedCrossRef
15.
Zurück zum Zitat O’Connor JE, Kimler BF, Morgan MC, Tempas KJ (1988) A flow cytometric assay for intracellular nonprotein thiols using mercury orange. Cytometry 9:529–532PubMedCrossRef O’Connor JE, Kimler BF, Morgan MC, Tempas KJ (1988) A flow cytometric assay for intracellular nonprotein thiols using mercury orange. Cytometry 9:529–532PubMedCrossRef
16.
Zurück zum Zitat Patel JM, Block ER, Hood CI (1984) Biochemical indices of cyclophosphamide-induced lung toxicity. Toxicol Appl Pharmacol 76:128–138PubMedCrossRef Patel JM, Block ER, Hood CI (1984) Biochemical indices of cyclophosphamide-induced lung toxicity. Toxicol Appl Pharmacol 76:128–138PubMedCrossRef
17.
Zurück zum Zitat Weijl NI, Cleton FJ, Osanto S (1997) Free radicals and antioxidants in chemotherapy-induced toxicity. Cancer Treat Rev 23:209–240PubMedCrossRef Weijl NI, Cleton FJ, Osanto S (1997) Free radicals and antioxidants in chemotherapy-induced toxicity. Cancer Treat Rev 23:209–240PubMedCrossRef
18.
Zurück zum Zitat Gottlieb M, Strober S, Kaplan HS (1979) Allogeneic marrow transplantation after total lymphoid irradiation (TLI): effect of dose/fraction, thymic irradiation, delayed marrow infusion, and presensitization. J Immunol 123:379–383PubMed Gottlieb M, Strober S, Kaplan HS (1979) Allogeneic marrow transplantation after total lymphoid irradiation (TLI): effect of dose/fraction, thymic irradiation, delayed marrow infusion, and presensitization. J Immunol 123:379–383PubMed
19.
Zurück zum Zitat Yung L, Weiss L, Abdul-Hai A, Kasir J, Reich S, Slavin S (2005) Induction of early post-transplant graft-vs-leukemia effects using intentionally mismatched donor lymphocytes and elimination of alloantigen-primed donor lymphocytes for prevention of graft-vs-host disease. Cancer Res 65:9735PubMedCrossRef Yung L, Weiss L, Abdul-Hai A, Kasir J, Reich S, Slavin S (2005) Induction of early post-transplant graft-vs-leukemia effects using intentionally mismatched donor lymphocytes and elimination of alloantigen-primed donor lymphocytes for prevention of graft-vs-host disease. Cancer Res 65:9735PubMedCrossRef
20.
Zurück zum Zitat Amer J, Goldfarb A, Fibach E (2004) Flow cytometric analysis of the oxidative status of normal and thalassemic red blood cells. Cytometry A 60:73–80PubMedCrossRef Amer J, Goldfarb A, Fibach E (2004) Flow cytometric analysis of the oxidative status of normal and thalassemic red blood cells. Cytometry A 60:73–80PubMedCrossRef
21.
Zurück zum Zitat Durken M, Agbenu J, Finckh B, Hubner C, Pichlmeier U et al (1995) Deteriorating free radical-trapping capacity and antioxidant status in plasma during bone marrow transplantation. Bone Marrow Transplant 15:757–762PubMed Durken M, Agbenu J, Finckh B, Hubner C, Pichlmeier U et al (1995) Deteriorating free radical-trapping capacity and antioxidant status in plasma during bone marrow transplantation. Bone Marrow Transplant 15:757–762PubMed
22.
Zurück zum Zitat Jonas CR, Puckett AB, Jones DP, Griffith DP, Szeszycki EE et al (2000) Plasma antioxidant status after high-dose chemotherapy: a randomized trial of parenteral nutrition in bone marrow transplantation patients. Am J Clin Nutr 72:181–189PubMed Jonas CR, Puckett AB, Jones DP, Griffith DP, Szeszycki EE et al (2000) Plasma antioxidant status after high-dose chemotherapy: a randomized trial of parenteral nutrition in bone marrow transplantation patients. Am J Clin Nutr 72:181–189PubMed
23.
Zurück zum Zitat Patel JM, Block ER (1985) Cyclophosphamide-induced depression of the antioxidant defense mechanisms of the lung. Exp Lung Res 8:153–165PubMed Patel JM, Block ER (1985) Cyclophosphamide-induced depression of the antioxidant defense mechanisms of the lung. Exp Lung Res 8:153–165PubMed
24.
Zurück zum Zitat Choi IC, Fung PC, Leung AY, Lie AK, Liang R (2001) Plasma nitric oxide is associated with the occurrence of moderate to severe acute graft-versus-host disease in haemopoietic stem cell transplant recipients. Haematologica 86:972–976PubMed Choi IC, Fung PC, Leung AY, Lie AK, Liang R (2001) Plasma nitric oxide is associated with the occurrence of moderate to severe acute graft-versus-host disease in haemopoietic stem cell transplant recipients. Haematologica 86:972–976PubMed
25.
Zurück zum Zitat Garside P, Hutton AK, Severn A, Liew FY, Mowat AM (1992) Nitric oxide mediates intestinal pathology in graft-vs.-host disease. Eur J Immunol 22:2141–2145PubMedCrossRef Garside P, Hutton AK, Severn A, Liew FY, Mowat AM (1992) Nitric oxide mediates intestinal pathology in graft-vs.-host disease. Eur J Immunol 22:2141–2145PubMedCrossRef
26.
Zurück zum Zitat Drobyski WR, Keever CA, Hanson GA, McAuliffe T, Griffith OW (1994) Inhibition of nitric oxide production is associated with enhanced weight loss, decreased survival, and impaired alloengraftment in mice undergoing graft-versus-host disease after bone marrow transplantation. Blood 84:2363–2373PubMed Drobyski WR, Keever CA, Hanson GA, McAuliffe T, Griffith OW (1994) Inhibition of nitric oxide production is associated with enhanced weight loss, decreased survival, and impaired alloengraftment in mice undergoing graft-versus-host disease after bone marrow transplantation. Blood 84:2363–2373PubMed
27.
Zurück zum Zitat Hoffman RA, Nussler NC, Gleixner SL, Zhang G, Ford HR et al (1997) Attenuation of lethal graft-versus-host disease by inhibition of nitric oxide synthase. Transplantation 63:94–100PubMedCrossRef Hoffman RA, Nussler NC, Gleixner SL, Zhang G, Ford HR et al (1997) Attenuation of lethal graft-versus-host disease by inhibition of nitric oxide synthase. Transplantation 63:94–100PubMedCrossRef
28.
Zurück zum Zitat Victor VM, Rocha M, De la Fuente M (2003) N-acetylcysteine protects mice from lethal endotoxemia by regulating the redox state of immune cells. Free Radic Res 37:919–929PubMedCrossRef Victor VM, Rocha M, De la Fuente M (2003) N-acetylcysteine protects mice from lethal endotoxemia by regulating the redox state of immune cells. Free Radic Res 37:919–929PubMedCrossRef
29.
Zurück zum Zitat Colombo AA, Alessandrino EP, Bernasconi P, Arcese GW, Rabusin M et al (1999) N-acetylcysteine in the treatment of steroid-resistant acute graft-versus-host-disease: preliminary results. Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Transplantation 68:1414–1416PubMedCrossRef Colombo AA, Alessandrino EP, Bernasconi P, Arcese GW, Rabusin M et al (1999) N-acetylcysteine in the treatment of steroid-resistant acute graft-versus-host-disease: preliminary results. Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Transplantation 68:1414–1416PubMedCrossRef
30.
Zurück zum Zitat Mikawa K, Akamatsu H, Nishina K, Shiga M, Maekawa N et al (1998) Propofol inhibits human neutrophil functions. Anesth Analg 87:695–700PubMedCrossRef Mikawa K, Akamatsu H, Nishina K, Shiga M, Maekawa N et al (1998) Propofol inhibits human neutrophil functions. Anesth Analg 87:695–700PubMedCrossRef
31.
Zurück zum Zitat Sagara Y, Hendler S, Khoh-Reiter S, Gillenwater G, Carlo D et al (1999) Propofol hemisuccinate protects neuronal cells from oxidative injury. J Neurochem 73:2524–2530PubMedCrossRef Sagara Y, Hendler S, Khoh-Reiter S, Gillenwater G, Carlo D et al (1999) Propofol hemisuccinate protects neuronal cells from oxidative injury. J Neurochem 73:2524–2530PubMedCrossRef
Metadaten
Titel
The oxidative status of blood cells in a murine model of graft-versus-host disease
verfasst von
Johnny Amer
Lola Weiss
Shoshana Reich
Michael Y. Shapira
Shimon Slavin
Eitan Fibach
Publikationsdatum
01.10.2007
Verlag
Springer-Verlag
Erschienen in
Annals of Hematology / Ausgabe 10/2007
Print ISSN: 0939-5555
Elektronische ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-007-0321-7

Weitere Artikel der Ausgabe 10/2007

Annals of Hematology 10/2007 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.